These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Development of prophylactic vaccines for genital and neonatal herpes. Jones CA; Cunningham AL Expert Rev Vaccines; 2003 Aug; 2(4):541-9. PubMed ID: 14711338 [TBL] [Abstract][Full Text] [Related]
55. Clinical studies with herpes simplex virus type 2 Curtis strain vaccine. Corey L Rev Infect Dis; 1991; 13 Suppl 11():S904-5. PubMed ID: 1664125 [No Abstract] [Full Text] [Related]
56. [Therapy of recurrent Herpes simplex]. Söltz-Szöts J Z Haut Geschlechtskr; 1971 Apr; 46(8):267-72. PubMed ID: 4324186 [No Abstract] [Full Text] [Related]
57. Prospects for a vaccine against herpes simplex virus types 1 and 2. Dix RD Prog Med Virol; 1987; 34():89-128. PubMed ID: 2821579 [No Abstract] [Full Text] [Related]
58. Animal studies on the efficacy of an inactivated herpes simplex virus vaccine against recurrent herpes infection. Scriba M Infection; 1978; 6(3):137-9. PubMed ID: 210127 [TBL] [Abstract][Full Text] [Related]
59. Double-blind, placebo-controlled trial of a herpes simplex virus type 2 glycoprotein vaccine in persons at high risk for genital herpes infection. Mertz GJ; Ashley R; Burke RL; Benedetti J; Critchlow C; Jones CC; Corey L J Infect Dis; 1990 Apr; 161(4):653-60. PubMed ID: 2181031 [TBL] [Abstract][Full Text] [Related]